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A B ST R AC T  
 
Aim: Candida infections develop especially in intensive care unit (ICU) patients and increase the mortality 
rates. So, early and accurate diagnosis of Candida infections and determination of risk factors are very 
important. We aimed to retrospectively investigate Candida infections in terms of species and risk factors for 
candidemia caused by fungi. 
Methods: Candida infections in critically ill patients hospitalized in the Intensive Care Unit of Bolu Abant 
Izzet Baysal University Training and Research Hospital between January 2014 and December 2018 were 
retrospectively analyzed. The isolated Candida species were evaluated according to the sample types. The 
cases were investigated in terms of mortality due to candidiasis, previously used antibiotics and isolated 
Candida species.  
Results: 34 Candida species isolated from fungal cultures in ICUs were included in the study. Candida 
albicans (73.5%) was the most prevalent species isolated (NAC 26.5%). Patients with Candida isolated in their 
urine samples (76%) had a higher mortality rate than patients with Candida from other regions. 
Conclusion: The results of our study suggest that the highest rate of candidiasis (88%) is in patients who 
received beta-lactam antibiotic treatment. In addition, we think that when Candida species are detected in the 
urine samples of critically ill patients in the ICU, care should be taken in terms of candidiasis. 
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Introduction 
Healthcare-associated infections (HAIs) are the 
infections that occur while receiving 
healthcare, that are developed in a hospital or 
another health center.  These infections are seen 
within the first 48 hours or in longer period after 
hospitalization or that occur within 30 days 
after receiving healthcare. Center for Disease 
Control and Prevention (CDC) reported that 1.7 
million hospitalized patients acquire HAIs 
every year while receiving a treatment for other 
health problems and more than 98.000 patients 
(one out of 17) die annually due to HAIs [1]. 
Candida species are opportunistic pathogenic 
microorganisms that are normally seen in 
human flora and may be the cause of an 
infection when the host’s immune system 
weakens [2]. As a result of improving 
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healthcare services, many diseases are no 
longer a threat to people and their life 
expectancy is prolonged. However, various 
opportunistic infections occur due to prolonged 
hospital stays and antibiotics used. With the 
increase of awareness, the number of reported 
opportunistic fungal infections started to 
increase. In HAIs, besides patient-related 
factors, procedures applied to patients, long-
term antibiotic use and candida colonization 
cause invasive candida infections with high 
mortality [3]. Candida species are the fourth 
most common pathogens causing nosocomial 
bloodstream infections [4]. The incidence of 
both Candida albicans (C. albicans) and non-
albicans Candida (NAC) species is increasing 
[5]. Determination of risk factors in patients 
with Candida infections will be useful for the 
prevention of mortality and morbidity in the 
future. Hence, this study aimed to determine 
risk factors for candida infections due to C. 
albicans and NAC species and compare the 
patients infected by these two species.  
 
Materials and Methods 
The study protocol was approved by the Bolu 
Abant İzzet Baysal University Research Ethics 
Committee (Date and decision number: 
2019/237). After getting approval from the 
local ethics committee, we retrospectively 
investigated candida infections in critically ill 
(A patient who needs monitoring to live 
because of organ/system failures or 
dysfunction) intensive care unit (ICU) patients 
in our institution between January 2014 and 
December 2018. Candida isolates were 
obtained from different clinical specimens such 
as urine, blood, sputum, wound, pleural fluid, 
and peritoneal fluid. Diagnosis of HAI 
candidiasis infection was made according to 
CDC criteria [6]. Only the first episode of 
candidiasis was considered in each patient, 
recurrent episodes were excluded. Patients 
were followed up by an infectious diseases 
specialist and infection control nurse of our 
hospital on daily basis and required antibiotic 
and antifungal treatments were managed 
according to the guidelines.  
 
Microbiologic sample identification  
Samples sent to our microbiology laboratory 
were cultivated into Sabouraud Dextrose Agar 
(SDA) (Oxoid, England) medium and 
incubated at 37°C for 24-48 hours. After 
incubation, yeast isolates in which growth was 
found were identified at the level of species by 
using germ tube test and VITEK 2 Compact 
(BioMérieux, France) fully automated 
identification system.  
Isolated candida species were evaluated 
according to the sample types. Cases were 
statistically compared in terms of mortality, 
previously used antibiotics and isolated candida 
species. Results were shown as the mean ± 
standard deviation for continuous variables, 
and the number of cases and percentage (%) for 
nominal variables. Categorical variables were 
evaluated using Pearson's Chi-square test and 
Fisher's exact test. Differences were considered 




A total of 34 candida species were isolated from 
fungal cultures of 34 patients (19 female and 15 
male). Cultures were obtained from different 
clinical specimens. Among the isolates, 25 
were C. albicans and 9 were NAC species. 17 
isolates were from blood samples, 13 from 
urine samples and 4 from other types of samples 
(pleural fluid, peritoneal fluid, wound and 
sputum). When isolated candida strains were 
distinguished as C. albicans and NAC, the 
highest rate of mortality was seen in patients in 
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whom C. albicans was isolated. When the 
clinical course of the patients was evaluated in 
terms of discharge and mortality, the highest 
mortality rate was found in patients in whom C. 
albicans were isolated from their urine samples. 
Mortality rates according to sample types of C. 



































When the patients were classified according to 
the antibiotics (Beta-lactam, Carbapenem, 
Quinolone, anti-anaerobic antibiotics, etc.) they 
used before C. albicans and NAC were isolated, 
the highest rate of candidiasis (88%) was seen 
in patients who received beta-lactam antibiotic 




































Table 1. Previously used antibiotics of the cases. 
 
Antibiotics Male (n/%) Female (n/%) Total (n/%) P 
Beta Lactam 17 / 89.50  13 / 86.70 30 / 88.20 
0.801 
Carbapenem 3 / 15.80 4 / 26.70 7 / 20.60 
0.436 
Quinolone 5 / 26.30 3 /   20 8 / 23.50 
0.666 
Anti-anaerobic 3 / 15.80 2 / 13.30 5 / 14.70 
0.841 
Anti-staphylococcal 3/ 15.80 5 / 33.30 8 / 23.50 0.231 
Other 6 / 31.60 3 /    20 9 / 26.50 0.447 
 
Table 2. Discharge and mortality rates of the cases according to culture type. 
 
Culture type  
Pathogen 
Total (n/%) 
Candida albicans (n/%) 
Non-albicans Candida 
(n/%) 
Discharge Exitus Discharge Exitus Discharge Exitus 
Urine 3 / 30 7 / 70 0 / 0 3 / 100 3/ 23.10 10 / 76.90 
Blood 8 / 61.50 5 / 38.5 1 / 25 3 / 75 9 / 52.90 8 / 47.10 
Sputum 0 / 0 0 / 0 1 / 100 0 / 0 1 / 100 0 / 0 
Wound 1 / 100 0 / 0 0 / 0 0 / 0 1 / 100 0 / 0 
Pleural Fluid 0 / 0 0 / 0 0 / 0 1 / 100 0 / 0 1 / 100 
Peritoneal 
Fluid 
1 / 100 0 / 0 0 / 0 0 / 0 1 / 100 0 / 0 
Total 13 / 52 12 / 48 2 / 22.20 7 / 77.80 15 / 44.10 19 / 55.90 
p 0.235 0.198   
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Candida infections are important health 
problems in critically ill patients in ICUs. These 
infections occur as a result of complicated 
surgical procedures, use of invasive medical 
devices and long term and broad-spectrum 
antibiotic treatment [5]. Thus, determining the 
risk factors for Candida infections will 
contribute to the decrease in occurrence of these 
types of infections. Recently, distribution of 
Candida species has shown an increase in 
favour of NAC rather than C. albicans [7].  Less 
response to antifungal treatment in NAC 
infections contribute to the increase in mortality 
rates [8-10]. In studies conducted in Turkey, C. 
albicans (CA) was generally isolated more 
often and the incidence rates of CA differs 


























In this study, the rate of CA among isolated 
Candida infections that were found in critically 
ill ICU patients was 73.5%. In our study, we 
also found the incidence of CA infections to be 
more than NAC infections. Compared with 
other studies, it was thought that the limited 
number of patient groups included in this study 
(critically ill) may lead to a higher incidence of 
CA.  
Candida infections are more commonly seen in 
patients hospitalized in ICUs due to many 
different reasons and also because of their weak 
immune system. In these kinds of patients, 
interventional procedures such as urinary 
catheter and intravenous catheter applications 
increase the susceptibility of patients against 




























Institution Subjects Duration Result  
Çagan et al.11 Marmara University 
Faculty of Medicine  
29 pediatric 
patients 
2011-2013 55.1% C. 
albicans 




2006-2016 54.2% C. 
albicans  
Kilincel et al.13  Duzce University, 




2012-2018 55% C. 
albicans 
Savci et al.14  Bozok University Research 
and Application Hospital 
42 clinical 
specimens 
2014-2016 66.7% C. 
albicans 
Yapar et al.15  Tertiary-care educational 
hospitals in Turkey 
83 Blood 
cultures 
2008-2009 45.8% C. 
albicans 




2011-2012 75.6% C. 
albicans 
Present study Bolu Abant İzzet Baysal 
University Hospital 
34 critically ill 
patients 
2014-2018 73.5% C. 
albicans 
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characterized with high rate of mortality [17]. 
The    most    common types of infections seen 
in ICUs are bloodstream infections, catheter-
associated infections and urinary tract 
infections [18]. In this study, the highest rate of 
Candida was isolated from blood (50%) and 
urine (38%) samples.  Mortality rate was higher 
in patients in whom candida was isolated from 
urine samples (76%) compared to the patients 
in whom candida was isolated from other sites. 
It should be considered that Candida isolated 
especially from urine samples of critically ill 
patients in ICUs may increase mortality.   
Multiple risk factors were attributed to Candida 
infections. One of the most important 
predisposing factors is long-term and broad-
spectrum antibiotic treatment [19]. In this 
study, when the patients were classified 
according to the types of antibiotics used before 
the detection of Candida infection, beta lactam 
antibiotics (88.2%) was found to be the most 
commonly used antibiotic group. Studies on the 
predisposing factors causing Candida 
infections are not sufficient in Turkey. 
However, Yapar et al. [15] and Büyüktuna et al. 
[19], revealed a relationship between long term 
antibiotic use and Candida infection.  
Our study has some limitations. Patients in 
ICUs who were included in the study were only 
analyzed according to the types of antibiotics 
used in terms of predisposing factors. 
Predisposing conditions such as hematopoietic 
stem sell or solid organ transplantation, 
diabetes mellitus, malignancy, trauma and renal 
failure were not questioned in patients. 
Moreover, the presence of urinary catheter and 
intravenous catheter was not investigated. In 
addition, several factors other than candida 
infection might have contributed to mortality. 
Therefore, we cannot definitely say that 
Candida infections were the only reason of 
mortality rates.  
In conclusion, it was concluded in this study 
that the highest rate of Candida infections in 
ICU patients belonged to C. albicans species. It 
should be considered that Candida species 
isolated from candida infections may affect the 
prognosis of patients. Early diagnosis and 
treatment in Candida infections will help to 
decrease mortality rates. In this study, the 
highest rate of mortality was seen in C. albicans 
infections strains isolated from urine samples. 
Therefore, we think that when Candida species 
are detected in the urine samples of critically ill 
patients in the ICU, care should be taken in 
terms of candidiasis. 
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